NCT03836664View on ClinicalTrials.gov

A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

April 14, 2018

Study Completion Date

April 14, 2018

Conditions
Migraine
Interventions
DRUG

Timolol

Timolol is a clear solution supplied in a plastic ophthalmic dispenser.

DRUG

Placebo

Placebo is normal saline solution that will be supplied in container matched to Timolol container.

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER

NCT03836664 - A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine | Biotech Hunter | Biotech Hunter